Results 241 to 250 of about 19,175 (268)

Malassezia spp. Yeasts of Emerging Concern in Fungemia

Frontiers in Cellular and Infection Microbiology, 2020
Malassezia spp. are lipid-dependent yeasts, inhabiting the skin and mucosa of humans and animals. They are involved in a variety of skin disorders in humans and animals and may cause bloodstream infections in severely immunocompromised patients.
Bart Theelen, Teunis Boekhout, Domenico Otranto   +2 more
exaly   +2 more sources

Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?

Antimicrobial Agents and Chemotherapy, 2021
We conducted an updated analysis on yeast isolates causing fungemia in patients admitted to a tertiary hospital in Madrid, Spain, over a 13-year period. We studied 896 isolates associated with 872 episodes of fungemia in 857 hospitalized patients between
Judith Díaz-García, Aina Mesquida, Elena Reigadas   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Epidemiology of Saccharomyces fungemia: a systematic review.

Medical Mycology, 2023
Fungemia due to Saccharomyces species are reported in considerable numbers, and the increase is attributed to using Saccharomyces boulardii probiotics in clinical settings.
K. Vinayagamoorthy, K. Pentapati, H. Prakash   +2 more
semanticscholar   +1 more source

Catheter-related Aspergillus Fungemia: Case Report and Literature Review

The Pediatric Infectious Disease Journal, 2023
Background: Aspergillus fungemia is encountered infrequently in clinical practice, even in the setting of invasive and disseminated disease. Prolonged Aspergillus fungemia secondary to a central venous catheter is notably rarer.
Ishminder Kaur, A. de St. Maurice
semanticscholar   +1 more source

Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic

Mycoses (Berlin), 2021
Bloodstream infection is an untoward effect of probiotic administration described by case reports and a cited reason to avoid using in the critically ill. The incidence rate of bloodstream infection in a population administered probiotics remains unknown.
Eric Wombwell, Bridget A. Bransteitter, L. Gillen   +2 more
semanticscholar   +1 more source

Fungemia in COVID‐19 ICU patients, a single medical center experience

Journal of Medical Virology, 2020
A known proportion of patients who are admitted for the novel coronavirus disease 2019 (COVID‐19) requires intensive care unit (ICU) level of care. Prolonged ICU stay is a risk factor for the development of nosocomial candidemia.
E. Bishburg, A. Okoh, S. Nagarakanti, M. Lindner, C. Migliore, Pratik Patel   +5 more
semanticscholar   +1 more source